First Patient in United Kingdom Treated With AcceleDent

HOUSTON, Oct. 29 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of
the AcceleDent System, which is an acceleration device for orthodontics, has
just completed the sale of the product to several key opinion leaders in the
United Kingdom. Doctors Gerry Bellman, Angelos Alvanos, and Asif Chatoo are
in private practice in the London area while Dr. Lars Christensen is in
private practice in Oxford.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients wear in the
mouth for twenty minutes daily. It generates a light microvibration force
which modulates the bone tissue remodeling process and accelerates orthodontic
tooth movement. The device is hands-free and allows the user flexibility to
carry out most routine tasks during the twenty-minute use session.

Dr. Bellman, an orthodontic specialist, is the first to treat a patient
outside of the USA where the Company has been conducting human clinical
trials. The patient is a 28-year old female initially being treated with a
fixed orthodontic appliance, with a treatment plan to later include a clear
aligner (Invisalign). The doctor and patient were very excited by how easy
the AcceleDent System is to use and look forward to a significantly reduced
treatment time. Dr. Bellman commented, "I was very excited to fit the first
AcceleDent appliance to a patient in the UK. It was extremely easy to fit and
my patient found it very simple to position in her mouth and use. I look
forward to monitoring the accelerated movement of her teeth over the coming
months."

Results from the initial clinical trial demonstrated an overall tooth movement
rate of 2.1 mm per month, which is 30% to 50% faster than what is reported in
the literature. This same study further demonstrated the safety of the
AcceleDent System through a detailed measurement and statistical analysis of
root resorption yielding mean values below 0.5 mm. It should be noted that
0.5 mm is well below the levels of 2 mm, or one-third of the root length,
considered clinically significant by researchers.

OrthoAccel Technologies, an early-stage, private company, is presently
controlling the availability of the AcceleDent System in the UK to a select
group of orthodontic specialists. In this manner, the product presentation,
doctor support materials, and Company logistical systems can be fine tuned
before a broader UK market release planned for October 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is the developer of the
AcceleDent System, a new device for enhancing orthodontic care. This device
has been studied to verify that it safely reduces treatment duration for
wearing braces by applying gentle pulsing forces in combination with standard
orthodontics to move teeth faster through accelerated bone remodeling.
Importantly, the device works complimentary with all existing orthodontic
technologies. AcceleDent is neither FDA cleared nor FDA approved; it is
currently investigational only in the United States. More information can be
requested at info@orthoaccel.com

Contact: Michael K. Lowe, 281.798.5318

SOURCE OrthoAccel Technologies, Inc.

Michael K. Lowe of OrthoAccel Technologies, Inc., +1-281-798-5318